GSK Investigational Site

Stadskanaal 9501 HE

0 studies enrolling now · 2 studies all time

What they study most

Irritable Colon, Neoplasms, Prostate

Studies at this site

• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
• Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS) — Completed